nosudamas for Normal to Dry Skin

Product NDC: 70064-003
11-digit product format: 700640003
Labeler code: 70064
Product ID: 70064-003_7f216d11-5349-4bb1-8918-ac9e8950774c
Type: HUMAN OTC DRUG
Nonproprietary name: Aluminum Zirconium Tetrachlorohydrex GLY
Dosage form: CREAM
Route: TOPICAL
Labeler: Geylanni International cosmetic developments LTD
Application: part350
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2015-09-04
Marketing end: 0000-00-00
Substance: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY
Active strength: 80 mg/mL
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	70064-003		I	Inactivated by FDA		2026-10-20
excluded package	package	70064-003	70064-003-01	I	Inactivated by FDA		2026-10-20

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	70064-003-01	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	70064-003-01	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	70064-003-01	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	70064-003-01	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	70064-003-01	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	70064-003-01	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	70064-003-01	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	70064-003-01	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	70064-003-01	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	70064-003-01	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	70064-003-01	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	70064-003-01	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	70064-003-01	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	70064-003-01	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	70064-003-01	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	70064-003-01	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	70064-003-01	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	70064-003-01	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	70064-003-01	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	70064-003-01	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	70064-003-01	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	70064-003-01	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
777d68c6-a5ab-e06c-d314-677b0b9af0c8	Product name	2	20240508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
70064-003-01	2020-01-31	C162847	48780-1	9d75b9d0-2173-f424-e053-dadaa90a57ce	nosudamas for Normal to Dry Skin

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
70064-003-01	nosudamas for Normal to Dry Skin	50 mL in 1 PACKAGE	CREAM	50		3

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Aluminum Zirconium Tetrachlorohydrex GLY	ACTIVE INGREDIENT	8O386558JE	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	ACTIVE MOIETY	8O386558JE	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
ALKYL (C12-15) BENZOATE	INACTIVE INGREDIENT	A9EJ3J61HQ	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
ALLANTOIN	INACTIVE INGREDIENT	344S277G0Z	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
ALOE VERA LEAF	INACTIVE INGREDIENT	ZY81Z83H0X	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
ALPHA-TOCOPHEROL ACETATE	INACTIVE INGREDIENT	9E8X80D2L0	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
BENZYL SALICYLATE	INACTIVE INGREDIENT	WAO5MNK9TU	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
BUTYLATED HYDROXYTOLUENE	INACTIVE INGREDIENT	1P9D0Z171K	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
CETYL ALCOHOL	INACTIVE INGREDIENT	936JST6JCN	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
COUMARIN	INACTIVE INGREDIENT	A4VZ22K1WT	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
CYCLOMETHICONE	INACTIVE INGREDIENT	NMQ347994Z	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
EDETIC ACID	INACTIVE INGREDIENT	9G34HU7RV0	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
GLYCERYL MONOSTEARATE	INACTIVE INGREDIENT	230OU9XXE4	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
HYDROXYETHYL CELLULOSE (100 MPA.S AT 2%)	INACTIVE INGREDIENT	R33S7TK2EP	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
LIMONENE, (+)-	INACTIVE INGREDIENT	GFD7C86Q1W	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
LINALOOL, (+/-)-	INACTIVE INGREDIENT	D81QY6I88E	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
MICA	INACTIVE INGREDIENT	V8A1AW0880	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
PEG-100 STEARATE	INACTIVE INGREDIENT	YD01N1999R	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
PEG-40 STEARATE	INACTIVE INGREDIENT	ECU18C66Q7	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
PEG-6 CAPRYLIC/CAPRIC GLYCERIDES	INACTIVE INGREDIENT	GO50W2HWO8	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
PHENYL TRIMETHICONE	INACTIVE INGREDIENT	DR0K5NOJ4R	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
PSEUDEVERNIA FURFURACEA	INACTIVE INGREDIENT	49ZMN09Q0K	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
SORBITAN MONOSTEARATE	INACTIVE INGREDIENT	NVZ4I0H58X	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8)	INACTIVE INGREDIENT	5041RX63GN	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3
WATER	INACTIVE INGREDIENT	059QF0KO0R	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
70064-003	NOSUDAMAS FOR NORMAL TO DRY SKIN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) CREAM [GEYLANNI INTERNATIONAL COSMETIC DEVELOPMENTS LTD]	3	Legacy NDC, 1 package rows	20150905_96b5d84d-acd0-48a7-aa83-3457a33c7f61.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
8O386558JE	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	134910-86-4	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
70064-003-01	70064000301	50 mL in 1 PACKAGE	50 ml	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
nosudamas for Normal to Dry Skin	Geylanni International cosmetic developments LTD \| Bio Direct Ltd.	2015-09-04	HUMAN OTC DRUG LABEL	3